Cytokine production in human and rat macrophages and dicatechol rooperol and esters

Biochemical Pharmacology

Volumn 52, Issue 7, 1996, Pages 991-998

  Guzdek, Amalia ^b   Nizankowska, Ewa ^b   Allison, Anthony C ^b   Kruger, Peter B ^b   Koj, Aleksander ^a  

^a JAGIELLONIAN UNIVERSITY   (Poland)

^b NONE

Author keywords

cytokine synthesis; endotoxin; macrophages; nitric oxide; rooperol

Indexed keywords

ANTIINFLAMMATORY AGENT; CATECHOL DERIVATIVE; CYTOKINE; DICATECHOL; ESCHERICHIA COLI ENDOTOXIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; LACTATE DEHYDROGENASE; LEUCINE; NITRIC OXIDE; RADIOISOTOPE; ROOPEROL; ROOPEROL DIACETATE; ROOPEROL DISULFATE; ROOPEROL ESTER; ROOPEROL TETRAACETATE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BLOOD CELL; CELL LINE; CELL VIABILITY; CONTROLLED STUDY; HISTIOCYTE; HUMAN; HUMAN CELL; LUNG ALVEOLUS MACROPHAGE; MONONUCLEAR CELL; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0011360887     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/0006-2952(96)00386-3     Document Type: Article

References (36)

1. 1. Feldman M, Brennan FM and Maini RN, Role of cytokines in autoimmune diseases. In: Human Cytokines: Their Role in Disease and Therapy. (Eds. Aggarval BB and Puri RK), pp. 185-194, Blackwell Science, Cambridge, MA, 1995.
2. 2. Allison AC, Lee JC and Eugui EM, Pharmacological regulation of the production of the proinflammatory cytokines TNFα and IL-1β. In: Human Cytokines: Their Role in Disease and Therapy. (Eds. Aggarval BB and Puri RK), pp. 689-713. Blackwell Science, Cambridge, MA, 1995.
3. 3. Remick DG, DeForge LE, Sullivan JF and Showell HJ, Profile of cytokines in synovial fluid specimens from patients with arthritis. Immunol. Invest. 21: 321-327, 1992.
4. 4. Barnes PJ and Liew FY, Nitric oxide and asthmatic inflammation. Immunol Today 16: 128-130, 1995.
5. 5. Heinrich PC, Castell JV and Andus T, Interleukin-6 and the acute phase response. Biochem J 265: 621-636, 1990.
6. 6. Koj A, Gauldie J and Baumann H, Biological perspectives of cytokines and hormone networks. In: Acute Phase Proteins, Molecular Biology, Biochemistry and Clinical Applications. (Eds. Mackiewicz A, Kushner I and Baumann H), pp. 275-287, CRC Press, Boca Raton, FL, 1993.
7. 7. Ulich TR, Guo K, Remick D, Del Castillo J and Yin S, Endotoxin-induced cytokine gene expression in vivo. III. IL-6 mRNA and serum protein expression and the in vivo hematologic effects of IL-6. J Immunol 146: 2316-2323, 1991.
8. 8. Zhong WW, Burke PA, Hand AT, Walsh MJ, Hughes LA and Forse RA, Regulation of cytokine mRNA expression in lipopolysaccharide-stimulated human macrophages. Arch Surg 128: 158-164, 1993.
9. 9. Cavaillon JM, Cytokines and macrophages. Biomed Pharmacother 48: 445-453, 1994.
10. 10. Holgate S, Mediators and cytokine mechanisms in asthma. Thorax 48: 103-109, 1993.
11. 11. Radomski MW, Palmer RMJ and Moncada S, Glucocorticoids inhibit the expression of an inducible, but not the constitutive, nitric oxide synthase in vascular endothelial cells. Proc Natl Acad Sci USA 87: 10043-10049, 1990.
12. 12. Van der Merwe MJ, Jenkins K, Theron E and Van der Walt BJ, Interaction of the dicatechols rooperol and nordihydroguaiaretic acid with oxidative systems in the human blood. Biochem Pharmacol 45: 303-311, 1993.
13. 2. Lancet 345: 436-438, 1995.
14. 14. Olsen EA, Abemethy L, Kulp-Shorten C, Callen JP, Glazer SD, Huntley A, McCray M, Monroe AB, Tschen E and Wolf JE Jr, A double-blind, vehicle-controlled study evaluating masoprocol cream in the treatment of actinic keratoses in the head and neck. J Am Acad Dermatol 24: 738-743, 1991.
15. 15. Bissett DL, Oelrich M and Hannon DP, Evaluation of a topical iron chelator in animals and human beings: short-term photoprotection by 2-furildioxime. J Am Acad Dermatol 31: 572-578, 1994.
16. 16. Kruger PB, de van Albrecht CF and Van Jaarsveld PP, Use of guanidine hydrochloride and ammonium sulphate in comprehensive in-line sorption enrichment of xenobiotics in biological fluids by high-performance liquid chromatography. J Chromatog 612: 191-198, 1993.
17. 17. Needham PL, The separation of human blood using monopoly resolving medium. J Immunol Meth 99: 283-284, 1986.
18. 18. American Thoracic Society, Guidelines. Summary and recommendation of a workshop on the investigational use of fiberoptic bronchoscopy and bronchoalveolar lavage in asthmatics. Am Rev Resp Dis 132: 180-182, 1985.
19. 19. Homolka J and Muller-Quernheim J, Increased interleukin-6 production by bronchoalveolar lavage cells in patients with active sarcoidosis. Lung 171: 173-183, 1993.
20. 20. Koj A and Guzdek A, Modified proteins as possible signals in the acute phase response. Ann N Y Acad Sci 762: 108-119, 1995.
21. 21. Koj A, Gauldie J, Sweeney GD, Regoeczi E and Sauder DN, The acute phase response of cultured hepatocytes. System characterization and the effect of human cytokines. Biochem J 224: 505-514, 1984.
22. 22. Ding AH, Nathan CF and Stuehr DJ, Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages: comparison of activating cytokines and evidence for independent production. J Immunol 141: 2407-2410, 1988.
23. 23. Plagemann PGW, Gregory KF and Wróblewski F, The electrophoretically distinct forms of mammalian lactic dehydrogenase. J Biol Chem 235: 2288-2293, 1960.
24. 24. Lowenstein CJ and Snyder SH, Nitric oxide, a novel biologic messenger. Cell 70: 705-707, 1992.
25. 25. Marcinkiewicz J, Grabowska A and Chain B, Nitric oxide upregulates the release of inflammatory mediators by mouse macrophages. Eur J Immunol 25: 947-951, 1995.
26. 26. Lee JC, Laydon JT, McDonnell PC, Gallagher TF, Kumar S, Green D, McNulty D, Blumenthal MJ, Heys JR, Landvatter SW, Strickler JE, McLaughlin MM, Siemens IR, Fisher SM, Livi GP, White JR, Adams JL and Young PR, A protein kinase involved in the regulation of inflammatory cytokine biosynthesis. Nature 372: 739-746, 1994.
27. 27. Rordorf-Adam C, Geiger T, Henn R, Arnold J, Solf R, Wiesenberg I, Ferrini PG and Vosbeck K, CGP 47969A: A novel inhibitor of the synthesis of inflammatory cytokines. Agents Actions 43: 53-59, 1994.
28. 28. McNiff PA, Laliberte RE, Svensson L, Pazoles CJ and Gabel CA, Inhibition of cytokine activation processes in vitro by tenidap, a novel antiinflammatory agent. Cytokine 7: 196-208, 1995.
29. 29. Rosenstein ED, Kunicka J, Kramer N and Goldstein G, Modification of cytokine production by piroxicam. J Rheumatol 21: 901-904, 1994.
30. 30. Eugui EM, DeLustro B, Rouhafza S, Ilnicka M, Lee SW, Wilhelm R and Allison AC, Some antioxidants inhibit, in a co-ordinate fashion, the production of tumor necrosis factor-α, IL-1β, and IL-6 by human peripheral blood mononuclear cells. Intern Immunol 6: 409-422, 1994.
31. 31. Dinarello C, The interleukin-1 family: 10 years of discovery. FASEB J 8: 1314-1325, 1994.
32. 32. Moncada S, Nistico G and Higgs EA (Eds.), Nitric Oxide: Brain and Immune System. Portland Press, Colchester, 1993.
33. 33. Zembala M, Siedlar M, Marcinkiewicz J and Pryjma J, Human monocytes are stimulated for nitric oxide release in vitro by some tumor cells but not by cytokines and lipopolysaccharide. Eur J Pharmacol 24: 435-439, 1994.
34. 34. Johnston RTB Jr, Enhancement of phagocytosis-associated oxidative metabolism as a manifestation of macrophage activation. In: Lymphokines (Ed. Pick E), vol. 3, pp. 33-52, New York, Academic Press, 1981.
35. 35. Beckman JS, Chen J, Ischiropoulos H and Crow JP, Oxidative chemistry of peroxynitrite. Methods Enzymol 233: 229-240, 1994.
36. 36. Robison TW, Sevanian A and Forman HJ, Inhibition of arachidonic acid release by nordihydroguaiauretic acid and its antioxidant action in rat alveolar macrophages and Chinese hamster lung fibroblasts. Toxicol Appl Pharmacol 105: 113-122, 1990.